FIELD: pharmaceutics.
SUBSTANCE: invention relates to new 3-aryl-4-(trifluoromethyl)-4H-spiro[chromeno[3,4-c]pyrrolidine-1,3'-oxindoles] of general formula I, as well as a method for their preparation.
EFFECT: new compounds have been obtained that have high cytotoxic activity in relation to the cells of human uterine neck carcinoma, HeLa line, and can be used as antitumor drugs.
2 cl, 1 dwg, 2 tbl, 26 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHYL-3-ARYL-3A-NITRO-4-(TRIFLUOROMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCHROMENO[3,4-C]PYRROLE-1-CARBOXYLATES, HAVING CYTOTOXIC ACTIVITY ON CELL LINE HUMAN CERVICAL CARCINOMA HELA, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2818191C1 |
| 6-TRIFLUORO(TRICHLORO)METHYL-SUBSTITUTED SPIRO[CHROMENO[3,4-a]PYRROLIZIDINE-11,3'-INDOLINE]-2'-ONES SHOWING ANTITUMOR ACTIVITY, AND THEIR PRODUCTION METHOD | 2020 |
|
RU2775605C2 |
| AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814738C1 |
| ARGLABIN DERIVATIVES WITH SELECTIVE CYTOTOXIC EFFECTS | 2023 |
|
RU2805915C1 |
| AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814259C1 |
| NEW ANTIMICROBIAL COMPOUNDS, THEIR USE FOR TREATMENT OF MAMMALIAN INFECTIONS AND NEW METABOLIC MECHANISM | 2017 |
|
RU2752568C2 |
| CONDENSED QUINOLINE DERIVATIVE AND USE THEREOF | 2005 |
|
RU2384571C2 |
| C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | 2017 |
|
RU2716502C2 |
| TRICYCLIC PYRROLE DERIVATIVES USEFUL AS 5-HT RECEPTOR MODULATORS | 2010 |
|
RU2567751C2 |
| PENTACYCLIC HETEROCYCLIC COMPOUND | 2020 |
|
RU2815382C2 |
